Tim Demuth Net Worth & Insider Trades

Tim Demuth - Chief Medical Officer, Pieris Pharmaceuticals, Inc

As of May 16, 2022

What is Tim Demuth's Net Worth?

The current estimated net worth of Pieris Pharmaceuticals, Inc's Chief Medical Officer, Tim Demuth, is estimated to be about $10.86K . Tim Demuth owns about 6,000 units of Pieris Pharmaceuticals, Inc common stock. In the last year at Pieris Pharmaceuticals, Inc, Tim Demuth has sold an estimated value of $0 worth.

What is Tim Demuth's Past Insider Trading?

Tim Demuth's largest purchase order was 6,000 units , worth over $10.26K on May 16, 2022. In total, Tim Demuth has made about 3 transactions over a year of their time at Pieris Pharmaceuticals, Inc. Tim Demuth usually trades in February, May and August, with the busiest year in 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Tim Demuth's' Mailing Address?

  • Mailing address is C/o Pieris Pharmaceuticals, Inc. 255 State Street, 9th Floor Boston MA 02109 MA

Pieris Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Stephen S. Yoder 2020 $535,000 $808,699 $173,875 $21,255 $1,538,829
Stephen S. Yoder 2019 $515,000 $815,670 $208,575 $54,353 $1,593,598
Hitto Kaufmann, Ph.D.* 2020 $330,583 $86,646 $107,143 $20,958 $545,330
Hitto Kaufmann, Ph.D.* 2019 $108,176 $956,299 $36,804 - $1,101,279
Thomas Bures 2020 $283,250 $154,038 $65,856 $11,400 $514,544
Thomas Bures 2019 $257,500 $152,938 $66,242 - $476,680
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1583648/000158364821000015/pirs2021proxystatement.htm

What are Pieris Pharmaceuticals, Inc's Past Insider Trades?

Pieris Pharmaceuticals, Inc's most recent insider trade came on May 16, 2022 by Tim Demuth who bought 6,000 units worth $10.26K . In the last 7 years, insiders at Pieris Pharmaceuticals, Inc have sold an estimated value of $25.85M and bought an estimated value of $3.65M worth of shares. Insider trading is most common in January, with the busiest year in 2017. The most active traders at the company are Michael Richman, Director,  Quang Chau Khuong,  and Christopher Kiritsy, Director .

PIERIS PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1